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This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based 
research. The summary is not intended to be a comprehensive summary of available evidence on 
COVID-19 but aims to make original documents easily accessible to decision makers which, if 
relevant to them, they should go to before making decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
10.08.2020 Effect of the 
COVID-19 
pandemic 
response on 
intrapartum 
care, stillbirth, 
and neonatal 
mortality 
outcomes in 
Nepal: a 
prospective 
observational 
study 
Lancet Global 
Health 
• Institutional childbirth 
reduced by more than 
half during lockdown, 
with increases in 
institutional stillbirth 
rate and neonatal 
mortality, and 
decreases in quality of 
care.  
• Some behaviours 
improved, notably 
hand hygiene and 
keeping the baby skin-
to-skin with their 
mother.  
• An urgent need exists 
to protect access to 
high quality 
intrapartum care and 
prevent excess deaths 
for the most 
vulnerable health 
system users during 
this pandemic period. 
Childbirth 
12.08.2020 Obesity and 
Mortality 
Among 
Patients 
Diagnosed 
With COVID-
19: Results 
From an 
Integrated 
Health Care 
Organization 
Annals of 
Internal 
Medicine 
• Among 6916 patients 
with COVID-19, there 
was a J-shaped 
association between 
BMI and risk for death, 
even after adjustment 
for obesity-related 
comorbidities.  
• Conclusions: Obesity 
plays a profound role 
in risk for death from 
COVID-19, particularly 
in male patients and 
younger populations. 
Our capitated system 
with more equalized 
health care access 
may explain the 
absence of effect of 
racial/ethnic and 
socioeconomic 
disparities on death. 
Our data highlight the 
leading role of severe 
obesity over correlated 
risk factors, providing 
a target for early 
intervention. 
Obesity 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
2020 The COVID-
19 
pandemic: 
diverse 
contexts; 
different 
epidemics—
how and 
why? 
BMJ 
• Learning from the variety of 
ways the COVID-19 
epidemic is unfolding across 
the globe can potentially 
contribute to solving the 
COVID-19 puzzle. 
• Paper compares COVID-19 
epidemics with other 
respiratory diseases, 
including other coronaviruses 
that circulate continuously; 
and highlights the critical 
unknowns and uncertainties 
that remain. 
 
08.08.2020 Children 
and COVID-
19: State-
Level Data 
Report 
American 
Academy of 
Paediatrics | 
State level 
data report 
• From July 16 to July 30, the 
number of new COVID-19 
cases in U.S. children rose 
40%, from 240,000 to 
340,000, according to a 
report from the American 
Academy of Pediatrics and 
the Children's Hospital 
Association. Over 70% of 
new child cases occurred in 
the South and the West. The 
overall case rate among 
children was 447 cases per 
100,000 children in the 
population. Most cases 
continued to be mild, with 
0.6%–8.9% requiring 
hospitalization and 0%-0.3% 
resulting in death. 
children 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
07.08.2020 Low-cost 
measurement 
of facemask 
efficacy for 
filtering 
expelled 
droplets 
during 
speech 
Science 
Advances 
• We have demonstrated a 
simple optical 
measurement method to 
evaluate the efficacy of 
masks to reduce the 
transmission of respiratory 
droplets during regular 
speech.  
• In proof-of-principle 
studies, we compared a 
variety of commonly 
available mask types and 
observed that some mask 
types approach the 
performance of standard 
surgical masks, while 
some mask alternatives, 
such as neck fleece or 
bandanas, offer very little 
protection.  
• Our measurement setup is 
inexpensive and can be 
built and operated by non-
experts, allowing for rapid 
evaluation of mask 
performance during 
speech, sneezing, or 
coughing. 
facemasks 
07.08.2020 Estimation of 
incubation 
period 
distribution of 
COVID-19 
using 
disease 
onset forward 
time: a novel 
cross-
sectional and 
forward 
follow-up 
study 
Science 
Advances 
• A novel low-cost and 
accurate method to 
estimate the incubation 
distribution of COVID-
19. We have conducted 
a cross-sectional and 
forward follow-up study 
by identifying those 
pre-symptomatic 
individuals at their time 
of departure from 
Wuhan and then 
following them until 
their symptoms 
developed. 
• The estimated 
probability that 
incubation period is 
longer than 14 days is 
between 5% to 10%. 
 
Incubation 
period 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
04.08.2020 SalivaDirect: 
Simple and 
sensitive 
molecular 
diagnostic 
test for 
SARS-CoV-
2 
surveillance 
medRxiv | 
pre-print (not 
peer-
reviewed) 
• Current bottlenecks for 
improving accessibility and 
scalability of SARS-CoV-2 
testing include diagnostic 
assay costs, complexity, and 
supply chain shortages. 
• SalivaDirect. The critical 
component of our approach is 
to use saliva instead of 
respiratory swabs, which 
enables non-invasive frequent 
sampling and reduces the 
need for trained healthcare 
professionals during collection. 
 
  
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
06.08.2020 Potential 
effects of 
disruption to 
HIV 
programmes in 
sub-Saharan 
Africa caused 
by COVID-19: 
results from 
multiple 
mathematical 
models 
Lancet HIV 
• This modelling study 
used five well 
described models of 
HIV epidemics 
(Goals, Optima HIV, 
HIV Synthesis, an 
Imperial College 
London model, and 
Epidemiological 
MODeling software 
[EMOD]) to estimate 
the effect of various 
potential disruptions 
to HIV prevention, 
testing, and 
treatment services 
on HIV-related 
deaths and new 
infections in sub-
Saharan Africa 
lasting 6 months 
over 1 year from 
April 1, 2020. 
• During the COVID-
19 pandemic, the 
primary priority for 
governments, 
donors, suppliers, 
and communities 
should focus on 
maintaining 
uninterrupted supply 
of ART drugs for 
people with HIV to 
avoid additional 
HIV-related deaths. 
The provision of 
other HIV 
prevention 
measures is also 
important to prevent 
any increase in HIV 
incidence. 
HIV 
08.08.2020 Impact of the 
COVID-19 
pandemic on 
gastrointestinal 
Endoscopy 
international 
open 
• Web-based survey. 
Thirty-one 
gastroenterologists 
from 14 countries in 
north, central, and 
gastrointestinal 
endoscopy 
endoscopy in 
Africa 
sub-Saharan Africa 
responded. 
• The majority of 
respondents 
reduced their 
endoscopy volume 
considerably. 
Personal protective 
equipment including 
FFP-2 masks were 
available in almost 
all participating 
centers. Pre-
endoscopy 
screening was 
performed as well. 
Conclusion The 
COVID-19 
pandemic has had a 
substantial impact 
on gastrointestinal 
endoscopy in most 
African countries; 
however, the impact 
may not have been 
as devastating as 
expected. 
12.08.2020 Burden of 
Covid-19 on 
mental health 
of older adults 
in a fragile 
health care 
system: the 
case of 
Nigeria: 
Dealing with 
inequalities 
and 
inadequacies 
International 
psycogeriatrics 
  
  
Leadership and governance 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
24.07.2020 University 
Lecturers 
and 
Students 
Could Help 
in 
Community 
Education 
About 
SARS-
CoV-2 
Infection in 
Uganda 
Health 
Services 
Insights  
• Aim of this study was to 
determine the knowledge, 
attitudes, and 
preparedness/practices of 
lecturers and students in the 
fight against COVID-19. 
• Descriptive cross-sectional 
study of 103 lecturers and 
students both men and 
women of age group 18 to 69 
years in western Uganda. 
• Study identifies lecturers and 
students as potential 
stakeholders in the fight 
against community 
transmission of COVID-19. 
 
Health systems 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
05.08.2020 A checklist 
to improve 
health 
system 
resilience 
to 
infectious 
disease 
outbreaks 
and 
natural 
hazards 
BMJ 
• Using data gathered from a 
scoping literature review, 
interviews with key 
informants and from 
stakeholders who attended a 
workshop held in Dhaka, 
Bangladesh, we developed a 
Health System Resilience 
Checklist (‘the checklist’).  
• The aim of the checklist is to 
measure the specific 
capacities, capabilities and 
processes that health 
systems need in order to 
ensure resilience in the face 
of both infectious disease 
outbreaks and natural 
hazards.  
• The checklist is intended to 
be adapted and used in a 
broad set of countries as a 
component of ongoing 
processes to ensure that 
health actors, institutions and 
Health 
systems 
populations can mount an 
effective response to 
infectious disease outbreaks 
and natural hazards while 
also maintaining core 
healthcare services. 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type 
10.08.2020 Multisystem inflammatory syndrome 
associated with COVID-19 in children in 
Pakistan 
Lancet Child and Adolescent 
Health | Correspondence  
10.08.2020 Applications of predictive modelling early in 
the COVID-19 epidemic 
Lancet Digital Health | Comment 
07.08.2020 SARS-CoV-2 epidemic in African 
countries—are we losing perspective? 
Lancet Infectious Diseases | 
Correspondence 
07.08.2020 Use of electronic tools for evidence-based 
preparedness and response to the COVID-
19 pandemic in the WHO African region 
The Lancet Digital Health | 
Comment 
29.07.2020 Developing a low-cost and accessible 
COVID-19 vaccine for global health 
PLOS | Viewpoints 
10.08.2020 Coronial autopsies identify the indirect 
effects of COVID-19 
Lancet Public Health | 
Correspondence 
10.08.2020 Communicating in a public health crisis Lancet Digital Health | Viewpoints 
10.08.2020 Providing maternal health services during 
the COVID-19 pandemic in Nepal 
Lancet Global Health | Comment 
11.08.2020 Forward planning for disaster-related mass 
gatherings amid COVID-19 
Lancet Planetary Health | 
Comment 
11.08.2020 Inclusion of pregnant women in COVID-19 
vaccine development 
Lancet Infectious Diseases | 
Comment 
12.08.2020 Precision Public Health as a Key Tool in the 
COVID-19 Response 
JAMA viewpoint 
12.08.2020 COVID-19 and Severe Obesity: A Big 
Problem? 
Annals of Internal Medicine | 
Editorial 
11.08.2020 Covid-19 misinformation sparks threats and 
violence against doctors in Latin America 
BMJ | Feature 
11.08.2020 Antibody therapies could be a bridge to a 
coronavirus vaccine — but will the world 
benefit? 
Nature | News 
12.08.2020 How to stop COVID-19 fuelling a resurgence 
of AIDS, malaria and tuberculosis 
Nature | Editorial 
  
 
Dashboards & Trackers 
Cases & deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living evidence & 
policy maps 
Current research 
including trials 
  Diagnostics   Treatments   Vaccines 
WHO sitreps  WHO Africa  Ghana  COVID-NMA  WHO    FIND SARS-
CoV-2 Test 
Tracker 
  Global COVID-
19 Clinical Trial 
Tracker 
  CEPI 
WHO dashboard  African 
Arguments  
Indonesia  EPPI Centre  WHO International 
Clinical Trials 
Registry Platform 
(ICTRP)  
 FIND SARS-
CoV-2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre LSHTM  
Johns Hopkins 
University  
European 
CDC  
Nigeria CDC  Norwegian 
Institute of Public 
Health  
Cytel   Serology-based 
tests for COVID-
19 
  Solidarity trial  COVID-19 
Oxford 
Vaccine Trial 
WEF    Sierra Leone   Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH   Our World in 
Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
 COVID-19 
Vaccine 
Tracker 
Our World in 
Data  
  Singapore   Our World in 
Data: C19 Policy 
responses 
COVID-evidence        
Global 5050    UK   IFPRI COVID-19 
Policy Response 
Portal 
Cochrane        
CEBM, University 
of Oxford  
  US   COVID-19 
Primer 
Clinicaltrials.gov        
Humanitarian 
Data Exchange  
     NIH LitCovid  UKCDR       
Information is 
Beautiful  
     WHO COVID-19 
Database 
        
LSHTM                
HealthMap 
(cases) 
              
The Commons 
Project 
              
SeroTracker         
  
 
C19 Resource Hubs  
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
 SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
 IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedne
ss 
Innovations 
Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
Health 
Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
    
COVID-19 
Digest 
UNHCR  South 
African 
Government 
JAMA 
Network 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   SAGE 
journals 
 Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetMap 
Team 
  Wiley       
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
FutureLearn 
LSHTM/UK PHRST 
weekly 
study 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid weekly search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary 
research papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease 
control and health system responses are included. Articles related to tackling the secondary impacts on other 
sectors are not included. Additional commentaries, opinions, and commissioned pieces are selected based on 
relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report  
This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before making 
decisions. The HES are not intended to replace medical or professional advice and the researcher or the K4D 
consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES alone. 
K4D services are provided by a consortium of leading organisations working in international development, led by 
the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield 
Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of 
Birmingham International Development Department (IDD) and the University of Manchester Humanitarian and 
Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. It is 
licensed for non-commercial purposes only. K4D cannot be held responsible for errors, 
omissions or any consequences arising from the use of information contained in this health 
evidence summary. Any views and opinions expressed do not necessarily reflect those of 
DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020.               
 
 
